Michael S. Aberman, VP Strategy and Investor Relat at REGENERON PHARMACEUTICALS INC (REGN), sold 7,500 shares at $334.24 ($2.5M) on 2014-02-18, disclosed to the SEC on 2014-02-19.
Scheduled sale ($2.5M) by VP Strategy and Investor Relat under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $323.30 | 710 | $230K | 9.4% |
| 2 | $323.30 | 3,142 | $1.0M | 41.4% |
| 3 | $324.81 | 100 | $32K | 1.3% |
| 4 | $325.36 | 200 | $65K | 2.7% |
| 5 | $327.56 | 300 | $98K | 4.0% |
| 6 | $328.60 | 100 |
| $33K |
| 1.3% |
| 7 | $329.34 | 200 | $66K | 2.7% |
| 8 | $330.87 | 200 | $66K | 2.7% |
| 9 | $331.16 | 200 | $66K | 2.7% |
| 10 | $332.41 | 1,100 | $366K | 14.9% |
| 11 | $333.50 | 948 | $316K | 12.9% |
| 12 | $334.24 | 300 | $100K | 4.1% |
| Total | $327.25 avg | 7,500 | $2.5M | 100% |
| Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |